UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial

Journal for immunotherapy of cancer, 2022-04, Vol.10 (4), p.e004424

2022

Volltextzugriff (PDF)

Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials

The oncologist (Dayton, Ohio), 2019-01, Vol.24 (1), p.96-102

2019

Volltextzugriff (PDF)

The Journal of Thoracic Oncology in the Next Decade

Journal of thoracic oncology, 2016-01, Vol.11 (1), p.8-8

Adjei, Alex A.

2016

Volltextzugriff (PDF)

Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing

Carcinogenesis (New York), 2012-07, Vol.33 (7), p.1270-1276

2012

Volltextzugriff (PDF)

MET: a promising anticancer therapeutic target

Nature reviews. Clinical oncology, 2012-06, Vol.9 (6), p.314-326

2012

Volltextzugriff (PDF)

The Coming of a New Age: The Journal of Thoracic Oncology Goes Electronic in 2024

Journal of thoracic oncology, 2023-10, Vol.18 (10), p.1257-1257

Adjei, Alex A.

2023

Volltextzugriff (PDF)

Effective Incorporation of Biomarkers into Phase II Trials

Clinical cancer research, 2009-03, Vol.15 (6), p.1898-1905

2009

Volltextzugriff (PDF)

Advances in Chemotherapy of Non-small Cell Lung Cancer

Chest, 2006-10, Vol.130 (4), p.1211-1219

2006

Volltextzugriff (PDF)

Multicenter Phase II Study of the Oral MEK Inhibitor, CI-1040, in Patients With Advanced Non-Small-Cell Lung, Breast, Colon, and Pancreatic Cancer

Journal of clinical oncology, 2004-11, Vol.22 (22), p.4456-4462

2004

Volltextzugriff (PDF)

Novel Designs and End Points for Phase II Clinical Trials

Clinical cancer research, 2009-03, Vol.15 (6), p.1866-1872

2009

Volltextzugriff (PDF)

Phase I Dose Escalation Study of the Anti–Insulin-Like Growth Factor-I Receptor Monoclonal Antibody CP-751,871 in Patients with Refractory Solid Tumors

Clinical cancer research, 2007-10, Vol.13 (19), p.5834-5840

2007

Volltextzugriff (PDF)

The role of Mcl-1 downregulation in the proapoptotic activity of the multikinase inhibitor BAY 43-9006

Oncogene, 2005-10, Vol.24 (46), p.6861-6869

2005

Volltextzugriff (PDF)

Phase II Trial of Pemetrexed Plus Bevacizumab for Second-Line Therapy of Patients With Advanced Non–Small-Cell Lung Cancer: NCCTG and SWOG Study N0426

Journal of clinical oncology, 2010-02, Vol.28 (4), p.614-619

2010

Volltextzugriff (PDF)

Phase I and Pharmacodynamic Study of the Oral MEK Inhibitor CI-1040 in Patients With Advanced Malignancies

Journal of clinical oncology, 2005-08, Vol.23 (23), p.5281-5293

2005

Volltextzugriff (PDF)

Allosteric MEK1/2 Inhibitor Refametinib (BAY 86-9766) in Combination with Sorafenib Exhibits Antitumor Activity in Preclinical Murine and Rat Models of Hepatocellular Carcinoma

Neoplasia (New York, N.Y.), 2013-10, Vol.15 (10), p.1161-IN24

2013

Volltextzugriff (PDF)

BRAF V600E disrupts AZD6244-induced abrogation of negative feedback pathways between extracellular signal-regulated kinase and Raf proteins

Cancer research (Chicago, Ill.), 2008-08, Vol.68 (15), p.6145-6153

2008

Volltextzugriff (PDF)

Understanding, recognizing, and managing toxicities of targeted anticancer therapies

CA: a cancer journal for clinicians, 2013-07, Vol.63 (4), p.249-279

2013

Volltextzugriff (PDF)

Human aromatase : Gene resequencing and functional genomics

Cancer research (Chicago, Ill.), 2005-12, Vol.65 (23), p.11071-11082

2005

Volltextzugriff (PDF)

FGFR Signaling as a Target for Lung Cancer Therapy

Journal of thoracic oncology, 2016-01, Vol.11 (1), p.9-20

2016

Volltextzugriff (PDF)

Tackling the High Cost of Oncology Drugs

Journal of thoracic oncology, 2021-11, Vol.16 (11), p.1774-1777

Adjei, Alex A.

2021

Volltextzugriff (PDF)

All That Glitters Is Not Gold: The Story of Rovalpituzumab Tesirine in SCLC

Journal of thoracic oncology, 2021-09, Vol.16 (9), p.1429-1433

2021

Volltextzugriff (PDF)

Antibody-drug conjugates: A promising novel therapeutic approach in lung cancer

Lung cancer (Amsterdam, Netherlands), 2022-01, Vol.163, p.96-106

2022

Volltextzugriff (PDF)

Lung cancer and metastasis: new opportunities and challenges

Cancer and metastasis reviews, 2015-06, Vol.34 (2), p.169-171

2015

Volltextzugriff (PDF)

In the clinic: ongoing clinical trials evaluating c-MET-inhibiting drugs

Therapeutic Advances in Medical Oncology, 2011-11, Vol.3 (1_suppl), p.S37-S50

2011

Volltextzugriff (PDF)

Management of Multifocal Lung Cancer: Results of a Survey

Journal of thoracic oncology, 2017-09, Vol.12 (9), p.1398-1402

2017

Volltextzugriff (PDF)

26 – 50 von 627

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(576)
Mit Volltextzugriff
(568)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(353)
Life Sciences & Biomedicine
(342)
Humans
(316)
Oncology
(288)
Female
(144)
Male
(138)
Biological And Medical Sciences
(129)
Medical Sciences
(128)
Aged
(125)
Middle Aged
(124)
Adult
(96)
Respiratory System
(85)
Tumors
(85)
Antineoplastic Agents
(79)
Lung Neoplasms - Drug Therapy
(79)
Neoplasms - Drug Therapy
(79)
Pharmacology. Drug Treatments
(78)
Aged, 80 And Over
(67)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(67)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(61)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial

Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials

The Journal of Thoracic Oncology in the Next Decade

Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing

MET: a promising anticancer therapeutic target

The Coming of a New Age: The Journal of Thoracic Oncology Goes Electronic in 2024

Effective Incorporation of Biomarkers into Phase II Trials

Advances in Chemotherapy of Non-small Cell Lung Cancer

Multicenter Phase II Study of the Oral MEK Inhibitor, CI-1040, in Patients With Advanced Non-Small-Cell Lung, Breast, Colon, and Pancreatic Cancer

Novel Designs and End Points for Phase II Clinical Trials

Phase I Dose Escalation Study of the Anti–Insulin-Like Growth Factor-I Receptor Monoclonal Antibody CP-751,871 in Patients with Refractory Solid Tumors

The role of Mcl-1 downregulation in the proapoptotic activity of the multikinase inhibitor BAY 43-9006

Phase II Trial of Pemetrexed Plus Bevacizumab for Second-Line Therapy of Patients With Advanced Non–Small-Cell Lung Cancer: NCCTG and SWOG Study N0426

Phase I and Pharmacodynamic Study of the Oral MEK Inhibitor CI-1040 in Patients With Advanced Malignancies

Allosteric MEK1/2 Inhibitor Refametinib (BAY 86-9766) in Combination with Sorafenib Exhibits Antitumor Activity in Preclinical Murine and Rat Models of Hepatocellular Carcinoma

BRAF V600E disrupts AZD6244-induced abrogation of negative feedback pathways between extracellular signal-regulated kinase and Raf proteins

Understanding, recognizing, and managing toxicities of targeted anticancer therapies

Human aromatase : Gene resequencing and functional genomics

FGFR Signaling as a Target for Lung Cancer Therapy

Tackling the High Cost of Oncology Drugs

All That Glitters Is Not Gold: The Story of Rovalpituzumab Tesirine in SCLC

Antibody-drug conjugates: A promising novel therapeutic approach in lung cancer

Lung cancer and metastasis: new opportunities and challenges

In the clinic: ongoing clinical trials evaluating c-MET-inhibiting drugs

Management of Multifocal Lung Cancer: Results of a Survey

Suchergebnisse filtern